RxDoctor Payments Data

Adam Irby, PA

Physician Assistant · Hinesville, GANPI 1659689628

Payments from drug & device makers

$1,626in general payments, 2019–2025

Across 68 payments — averaging $23.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$329
  • AbbVie$221
  • Otsuka America Pharmaceutical, Inc.$194
  • Neuronetics, Inc.$174
  • Johnson & Johnson$124
  • Vanda Pharmaceuticals Inc.$120
  • plus $463 from 11 others

What the payments were for

  • Food & beverage$1,626100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,626 in reported general payments places this provider in the 75th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$59,712
Medicare patients
177
Services billed
1,275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl47$74,089
AustedoDeutetrabenazine18$68,359
RexultiBrexpiprazole26$40,591
Lurasidone Hcl135$40,225
Invega SustennaPaliperidone Palmitate16$40,062
CaplytaLumateperone Tosylate13$30,624
AuvelityDextromethorphan Hbr/Bupropion12$12,967
Aripiprazole159$12,183
Quetiapine Fumarate566$9,085
Divalproex Sodium ErDivalproex Sodium157$8,504
Ziprasidone Hcl97$8,209
BelsomraSuvorexant14$7,003
Desvenlafaxine Succinate ErDesvenlafaxine Succinate103$6,403
Paliperidone ErPaliperidone41$5,430
Trazodone Hcl488$4,843

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$221$74,08947 claims
Otsuka America Pharmaceutical, Inc.Rexulti$194$40,59126 claims
Johnson & JohnsonInvega Sustenna$124$40,06216 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$37$30,62413 claims
Axsome Therapeutics, Inc.Auvelity$329$12,96712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Hinesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →